share_log

MannKind | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Chief Executive Officer Castagna Michael

曼恩凱德生物醫療 | 4/A:持股變動聲明(修正)-首席執行官 Castagna Michael

SEC announcement ·  2023/10/03 21:00
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息